None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Female trial participants in general good health determined from a recent medical health history. 2) Trial participants of age group 18-45 years (both age inclusive). 3) Trial participants must meet one (and only one) of the following skin-type specifications (normal skin and atopic dry skin in 1:1 ratio): a. Participants with normal skin. b. Participants with atopic dry prone skin. 4) Trial participants with Fitzpatrick skin type of III, IV and V. 5) Trial participants willing to give a voluntary written informed consent 6) Trial participants willing to abide by and comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1) Trial participants with signs of significant local irritation or active dermatological conditions (eg., psoriasis, or skin infection). 2) Trial participants taking any medication which the Investigator believes may influence the interpretation of the data. 3) Trial participants having chronic illness or who have undergone major surgery in the last year. 4) Trial participants undergoing treatment for any skin condition. 5) Trial participants who are pregnant or nursing (self- declared).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Difference in skin barrier function and skin hydration between Normal and Atopic prone dry skin assessed by instrumental and clinical scoring. 2. Differences in tape strip derived biomarker levels and lipid profile characterization between normal skin and atopic-prone dry skin groups. Timepoint: Day 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in skin barrier related outcomes and biomarker profiles between study sites.Timepoint: Day 1 | — |
Countries
India
Contacts
MS Clinical Research Pvt. Ltd